Dr Donald S Mcleod, MD | |
5665 Peachtree Dunwoody Rd Ne, Atlanta, GA 30342-1701 | |
(404) 851-7324 | |
(404) 843-2627 |
Full Name | Dr Donald S Mcleod |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 48 Years |
Location | 5665 Peachtree Dunwoody Rd Ne, Atlanta, Georgia |
Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1952319170 | NPI | - | NPPES |
00231118A | Medicaid | GA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208VP0014X | Pain Medicine - Interventional Pain Medicine | 022591 (Georgia) | Secondary |
207L00000X | Anesthesiology | 022591 (Georgia) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Redmond Anesthesia And Pain Treatment, Pc | 4880841741 | 41 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Entity Name | Concordia Anesthesiology Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1619296464 PECOS PAC ID: 8325172885 Enrollment ID: O20100819000220 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Entity Name | Redmond Anesthesia And Pain Treatment, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1821350984 PECOS PAC ID: 4880841741 Enrollment ID: O20120828000499 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Entity Name | Mak Anesthesia Holdings, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912452939 PECOS PAC ID: 4284917204 Enrollment ID: O20170216001563 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Entity Name | Mak Anesthesia Northside Affiliates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1609390103 PECOS PAC ID: 7315203718 Enrollment ID: O20171116002499 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Entity Name | Rome Anesthesia Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740777317 PECOS PAC ID: 8921355504 Enrollment ID: O20180727002778 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Donald S Mcleod, MD 5671 Peachtree Dunwoody Rd Ne, Suite 530, Atlanta, GA 30342-5000 Ph: (404) 257-1415 | Dr Donald S Mcleod, MD 5665 Peachtree Dunwoody Rd Ne, Atlanta, GA 30342-1701 Ph: (404) 851-7324 |
News Archive
Cancerous brain tumors appear to respond favorably to the drug temozolomide when used as primary chemotherapy after surgery, and the treatment appears to work best in people missing a certain gene, according to a study published in the May 22, 2007, issue of Neurology, the scientific journal of the American Academy of Neurology.
People with hard-to-reach cancers in the kidney, gut and prostate will have improved hope for early diagnosis and treatment with new research aimed at increasing the shelf life of revolutionary radiation drugs.
Researchers at the University of Alabama at Birmingham have identified a chemical pathway that may be associated with seizures and shorter patient survival in some patients with malignant glioma, the most common and deadly form of brain tumor. In findings published May 27 in Science Translational Medicine, the researchers suggest that a transporter known as SXC is responsible for boosting levels of glutamate in the brains of some glioma patients.
Researchers at Karolinska Institutet and Karolinska University Hospital in Sweden have compared the ability of three different artificial intelligence (AI) algorithms to identify breast cancer based on previously taken mammograms.
› Verified 6 days ago
Jinal Achyutkumar Khamar, CAA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1968 Peachtree Rd Nw, Atlanta, GA 30309 Phone: 404-605-5000 | |
Sarah Elizabeth Dunseath, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-778-7777 | |
Dr. John J Byrne, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5665 Peachtree Dunwoody Rd Ne, Atlanta, GA 30342 Phone: 404-851-7324 Fax: 404-843-2627 | |
William O Prince, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1968 Peachtree Road Nw, Atlanta, GA 30309 Phone: 404-351-1745 Fax: 404-351-7121 | |
Dr. Joanna Miriam Schindler, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 69 Jesse Hill Jr Dr Se, Atlanta, GA 30303 Phone: 404-556-1497 | |
Dr. Sriharsha S Tanguturi, M.D. Anesthesiology Medicare: May Accept Medicare Assignments Practice Location: 200 Inman Ln Ne, Atlanta, GA 30307 Phone: 404-824-3262 | |
Shelly Stephens Norris, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 550 Peachtree St Ne, Department Of Anesthesiology, Atlanta, GA 30308 Phone: 404-558-7254 |